Name of applicant:
|
GSK plc
| |||
Name of scheme:
|
GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan
| |||
Period of return:
|
From:
|
1 May 2022
|
To:
|
31 October 2022
|
Balance of unallotted securities under scheme(s) from previous return:
|
44,219
| |||
Plus:The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
| |||
Less:Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
0
| |||
Equals:Balance under scheme(s) not yet issued/allotted at end of period:
|
44,219
|
Name of applicant:
|
GSK plc
| |||
Name of scheme:
|
GlaxoSmithKline plc Share Save Plan 2012
| |||
Period of return:
|
From:
|
1 May 2022
|
To:
|
31 October 2022
|
Balance of unallotted securities under scheme(s) from previous return:
|
1,373,495
| |||
Plus:The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
| |||
Less:Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
251,620
| |||
Equals:Balance under scheme(s) not yet issued/allotted at end of period:
|
1,121,875
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
GSK plc published this content on 15 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 November 2022 11:51:17 UTC.